Zymeworks Newsroom

Wells Fargo Downgrades Zymeworks(ZYME.US) to Hold Rating, Raises Target Price to $14

Moomoo NewsDec 20, 2024 13:37 ET

Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14

BenzingaDec 19, 2024 09:55 ET

Zymeworks Raised to Overweight From Neutral by JP Morgan

Dow JonesDec 16, 2024 07:17 ET

Zymeworks Analyst Ratings

BenzingaDec 16, 2024 07:07 ET

J.P. Morgan Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $18

Moomoo NewsDec 16, 2024 05:31 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)

TipRanksDec 16, 2024 01:33 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsDec 13, 2024 08:33 ET

Zymeworks Analyst Ratings

BenzingaNov 22, 2024 06:55 ET

Zymeworks Hold Rating: Balancing FDA Milestones With Market Valuation and Future Risks

TipRanksNov 22, 2024 06:27 ET

Leerink Partners Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $26

Moomoo NewsNov 21, 2024 16:31 ET

Zymeworks Analyst Ratings

BenzingaNov 7, 2024 07:17 ET

Leerink Partners Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $25

Moomoo NewsNov 7, 2024 06:31 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsNov 1, 2024 08:31 ET

Zymeworks Analyst Ratings

BenzingaNov 1, 2024 07:24 ET

Zymeworks Analyst Ratings

BenzingaOct 28, 2024 09:54 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $28

Moomoo NewsOct 28, 2024 08:34 ET

Maintaining Neutral: Hold Rating on Zymeworks Amidst Preclinical Progress and Upcoming Catalysts

TipRanksSep 25, 2024 06:17 ET

Zymeworks Analyst Ratings

BenzingaSep 18, 2024 07:07 ET

Zymeworks' Hold Rating Amidst Promising Data and Competitive HER2+ GEA Treatment Landscape

TipRanksSep 18, 2024 06:29 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsSep 10, 2024 08:31 ET